Ipilimumab with temozolomide vs. temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomized phase II clinical trial
Authors
Sarah Jefferies (ORCID: https://orcid.org/0000-0001-7660-4466)
Ipilimumab with temozolomide vs. temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomized phase II clinical trial
Sarah Jefferies, Catherine McBain, Jonathan Cook, Puneet Plaha et al.
Citations
2 citations
Journal
Neuro-Oncology Advances
Topics
Glioma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
3.25
article
Ipilimumab with temozolomide vs. temozolomide alone after surgery and chemoradiotherapy in recently diagnosed glioblastoma: a randomized phase II clinical trial
Sarah Jefferies, Catherine McBain, Jonathan Cook, Puneet Plaha, Fiona Harris, Paul Mulholland, Samia Hussain, Nicholas F. Brown, Susan Dutton, Anup Vinayan, Stéphanie Lévy, Claire Brooks, Sharon Peoples, Timothy J. Coutts, Stasya Ng, Lucy Brazil
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Neuro-Oncology AdvancesVol. 7(1)
Institutions
University College Hospital (GB), Guy's and St Thomas' NHS Foundation Trust (GB), Western General Hospital (GB), Royal London Hospital (GB), Cancer Research UK (GB), Nuffield Orthopaedic Centre (GB), Cambridge University Hospitals NHS Foundation Trust (GB), Edinburgh Cancer Research (GB), University of Oxford (GB), Thomas Foundation (AU), Mount Vernon Cancer Centre (GB), Respiratory Clinical Trials (GB), Oxford Centre for Diabetes, Endocrinology and Metabolism (GB), The Christie NHS Foundation Trust (GB), Oxford University Hospitals NHS Trust (GB), CRUK Lung Cancer Centre of Excellence (GB), University College London (GB)
Funders
Bristol-Myers Squibb, United Kingdom Clinical Research Collaboration, Cancer Research UK, National Institute for Health and Care Research, University of Oxford